Q3 FY2024 Earnings
Financial report interval: 2024.03.30 - 2024.06.30
Overview: Arch Therapeutics, Inc.(ARTH) the Revenue is 30.91 K (+132.6%);the EBIT is -1.021 M (-0.7%);the EPS is -1.44 (-0.86%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B132.55%
----
----
EBIT
-0.00B0.70%
----
----
EPS
-1.43660.86%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf